Cargando…

Patients’ worries before starting antiretroviral therapy and their association with treatment adherence and outcomes: a prospective study in rural Uganda, 2004 - 2009

BACKGROUND: In HIV-infected persons, good adherence to antiretroviral therapy (ART) is essential for successful treatment outcomes. Patients’ worries before starting ART may affect their ART adherence and treatment outcomes. METHODS: Between 2004 and 2009, HIV-infected individuals in a prospective c...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayanja, Billy N, Ekoru, Kenneth, Namugenyi, Harriet, Lubega, Rosemary, Mugisha, Joseph O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655014/
https://www.ncbi.nlm.nih.gov/pubmed/23651541
http://dx.doi.org/10.1186/1756-0500-6-187
_version_ 1782269813741060096
author Mayanja, Billy N
Ekoru, Kenneth
Namugenyi, Harriet
Lubega, Rosemary
Mugisha, Joseph O
author_facet Mayanja, Billy N
Ekoru, Kenneth
Namugenyi, Harriet
Lubega, Rosemary
Mugisha, Joseph O
author_sort Mayanja, Billy N
collection PubMed
description BACKGROUND: In HIV-infected persons, good adherence to antiretroviral therapy (ART) is essential for successful treatment outcomes. Patients’ worries before starting ART may affect their ART adherence and treatment outcomes. METHODS: Between 2004 and 2009, HIV-infected individuals in a prospective cohort study in rural Uganda were assessed for ART eligibility. A counsellor explained the ART eligibility criteria, adherence and side effects, and recorded the patients’ worries related to ART. Every quarter, patients who initiated ART had clinical, immunological (CD4 cell counts) and virological (viral loads) assessments, and data were collected on ART adherence using patients’ self-reports and pill counts. We describe the patients’ worries and examine their association with ART adherence, and immunological and virological outcomes. RESULTS: We assessed 421 patients, 271 (64%) were females, 318 (76%) were aged 30 years and above and 315 (75%) were eligible for ART. 277 (66%) reported any worry, and the proportions were similar by sex, age group and ART eligibility status. The baseline median CD4 counts and viral loads were similar among patients with any worry and those with no worry. The commonest worries were: fear of HIV serostatus disclosure; among 69 (16%) participants, lack of food when appetite improved after starting ART; 50 (12%), concurrent use of other medications; 33 (8%), adherence to ART; 28 (7%) and problems concerning condom use; 27 (6%). After 24 months or more on ART, patients who reported any worry had made more scheduled ART refill visits than patients who reported no worry (p<0.01), but the annual CD4 cell increases were similar (p=0.12). After one year on ART, patients who reported any worry had greater virological suppression than patients who reported no worry (p<0.05). CONCLUSIONS: Despite the lack of significant associations of worries with unfavourable ART outcomes, physicians and counsellors should assist patients in overcoming their worries that can cause stress and discomfort. Food supplements may be desirable for some patients initiating ART.
format Online
Article
Text
id pubmed-3655014
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36550142013-05-16 Patients’ worries before starting antiretroviral therapy and their association with treatment adherence and outcomes: a prospective study in rural Uganda, 2004 - 2009 Mayanja, Billy N Ekoru, Kenneth Namugenyi, Harriet Lubega, Rosemary Mugisha, Joseph O BMC Res Notes Research Article BACKGROUND: In HIV-infected persons, good adherence to antiretroviral therapy (ART) is essential for successful treatment outcomes. Patients’ worries before starting ART may affect their ART adherence and treatment outcomes. METHODS: Between 2004 and 2009, HIV-infected individuals in a prospective cohort study in rural Uganda were assessed for ART eligibility. A counsellor explained the ART eligibility criteria, adherence and side effects, and recorded the patients’ worries related to ART. Every quarter, patients who initiated ART had clinical, immunological (CD4 cell counts) and virological (viral loads) assessments, and data were collected on ART adherence using patients’ self-reports and pill counts. We describe the patients’ worries and examine their association with ART adherence, and immunological and virological outcomes. RESULTS: We assessed 421 patients, 271 (64%) were females, 318 (76%) were aged 30 years and above and 315 (75%) were eligible for ART. 277 (66%) reported any worry, and the proportions were similar by sex, age group and ART eligibility status. The baseline median CD4 counts and viral loads were similar among patients with any worry and those with no worry. The commonest worries were: fear of HIV serostatus disclosure; among 69 (16%) participants, lack of food when appetite improved after starting ART; 50 (12%), concurrent use of other medications; 33 (8%), adherence to ART; 28 (7%) and problems concerning condom use; 27 (6%). After 24 months or more on ART, patients who reported any worry had made more scheduled ART refill visits than patients who reported no worry (p<0.01), but the annual CD4 cell increases were similar (p=0.12). After one year on ART, patients who reported any worry had greater virological suppression than patients who reported no worry (p<0.05). CONCLUSIONS: Despite the lack of significant associations of worries with unfavourable ART outcomes, physicians and counsellors should assist patients in overcoming their worries that can cause stress and discomfort. Food supplements may be desirable for some patients initiating ART. BioMed Central 2013-05-07 /pmc/articles/PMC3655014/ /pubmed/23651541 http://dx.doi.org/10.1186/1756-0500-6-187 Text en Copyright © 2013 Mayanja et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mayanja, Billy N
Ekoru, Kenneth
Namugenyi, Harriet
Lubega, Rosemary
Mugisha, Joseph O
Patients’ worries before starting antiretroviral therapy and their association with treatment adherence and outcomes: a prospective study in rural Uganda, 2004 - 2009
title Patients’ worries before starting antiretroviral therapy and their association with treatment adherence and outcomes: a prospective study in rural Uganda, 2004 - 2009
title_full Patients’ worries before starting antiretroviral therapy and their association with treatment adherence and outcomes: a prospective study in rural Uganda, 2004 - 2009
title_fullStr Patients’ worries before starting antiretroviral therapy and their association with treatment adherence and outcomes: a prospective study in rural Uganda, 2004 - 2009
title_full_unstemmed Patients’ worries before starting antiretroviral therapy and their association with treatment adherence and outcomes: a prospective study in rural Uganda, 2004 - 2009
title_short Patients’ worries before starting antiretroviral therapy and their association with treatment adherence and outcomes: a prospective study in rural Uganda, 2004 - 2009
title_sort patients’ worries before starting antiretroviral therapy and their association with treatment adherence and outcomes: a prospective study in rural uganda, 2004 - 2009
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655014/
https://www.ncbi.nlm.nih.gov/pubmed/23651541
http://dx.doi.org/10.1186/1756-0500-6-187
work_keys_str_mv AT mayanjabillyn patientsworriesbeforestartingantiretroviraltherapyandtheirassociationwithtreatmentadherenceandoutcomesaprospectivestudyinruraluganda20042009
AT ekorukenneth patientsworriesbeforestartingantiretroviraltherapyandtheirassociationwithtreatmentadherenceandoutcomesaprospectivestudyinruraluganda20042009
AT namugenyiharriet patientsworriesbeforestartingantiretroviraltherapyandtheirassociationwithtreatmentadherenceandoutcomesaprospectivestudyinruraluganda20042009
AT lubegarosemary patientsworriesbeforestartingantiretroviraltherapyandtheirassociationwithtreatmentadherenceandoutcomesaprospectivestudyinruraluganda20042009
AT mugishajosepho patientsworriesbeforestartingantiretroviraltherapyandtheirassociationwithtreatmentadherenceandoutcomesaprospectivestudyinruraluganda20042009